Journal article

Ibrutinib in the treatment of chronic lymphocytic leukemia: 5 years on

Stefano Molica, Estella Matutes, Constantine Tam, Aaron Polliack

Hematological Oncology | WILEY | Published : 2019

DOI: 10.1002/hon.2695

Citation metrics

6Web of Science
4Scopus

Keywords

Pyrimidines
Efficacy
Science & Technology
Humans
Prognosis
Hematology
Resistance
Multicenter
Long-Term Follow-Up
Cyclophosphamide
Pyrazoles
Protein Kinase Inhibitors
Oncology
Fludarabine
Ibrutinib Combinations
Agammaglobulinaemia Tyrosine Kinase
Rituximab
Life Sciences & Biomedicine
Idelalisib
Kinase Inhibitor Ibrutinib
Venetoclax
Leukemia, Lymphocytic, Chronic, B-Cell
Ibrutinib
Chemoimmunotherapy
Cll